Your browser doesn't support javascript.
loading
2023 Consensus of Taiwan Society of Cardiology on the Pharmacological Treatment of Chronic Heart Failure.
Chiang, Chern-En; Hung, Chung-Lieh; Wu, Yen-Wen; Lin, Tsung-Hsien; Ueng, Kwo-Chang; Sung, Shih-Hsien; Wu, Cho-Kai; Chao, Ting-Hsing; Lin, Hung-Ju; Lin, Yen-Hung; Huang, Jin-Long; Chen, Michael Yu Chih; Lin, Po-Lin; Chao, Tze-Fan; Cheng, Hao-Min; Liu, Ming-En; Wang, Tzung-Dau; Yeh, Hung-I; Li, Yi-Heng; Liu, Ping-Yen; Yin, Wei-Hsian; Hsieh, I-Chang; Wang, Chun-Chieh; Chen, Chen-Huan; Chu, Pao-Hsien; Lin, Shing-Jong; Yeh, San-Jou; Lin, Jiunn-Lee; Hwang, Juey-Jen; Hung, Huei-Fong; Chen, Wen-Jone; Hou, Charles Jia-Yin.
Afiliação
  • Chiang CE; General Clinical Research Center.
  • Hung CL; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital.
  • Wu YW; School of Medicine, National Yang Ming Chiao Tung University.
  • Lin TH; Division of Cardiology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei.
  • Ueng KC; Institute of Biomedical Sciences, MacKay Medical College.
  • Sung SH; School of Medicine, National Yang Ming Chiao Tung University.
  • Wu CK; Division of Cardiology, Cardiovascular Medical Center, Far Eastern Memorial Hospital, New Taipei City.
  • Chao TH; Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital.
  • Lin HJ; Faculty of Medicine and Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung.
  • Lin YH; Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung.
  • Huang JL; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital.
  • Chen MYC; School of Medicine, National Yang Ming Chiao Tung University.
  • Lin PL; Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei.
  • Chao TF; Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan.
  • Cheng HM; Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei.
  • Liu ME; Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei.
  • Wang TD; National Taiwan University College of Medicine, Taipei.
  • Yeh HI; Department of Medical Education, Taichung Veterans General Hospital.
  • Li YH; Department of Post-Baccalaureate Medicine, College of Medicine, National Chung-Hsing University, Taichung.
  • Liu PY; Division of Cardiology, Department of Internal Medicine, Buddhist Tzu Chi General Hospital, Hualien.
  • Yin WH; Division of Cardiology, Hsinchu MacKay Memorial Hospital, Hsinchu.
  • Hsieh IC; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital.
  • Wang CC; Institute of Clinical Medicine, and Cardiovascular Research Center, National Yang Ming Chiao Tung University.
  • Chen CH; Program of Interdisciplinary Medicine, National Yang Ming Chiao Tung University School of Medicine.
  • Chu PH; Division of Faculty Development, Taipei Veterans General Hospital.
  • Lin SJ; Division of Cardiology, Hsinchu MacKay Memorial Hospital, Hsinchu.
  • Yeh SJ; Cardiovascular Center and Divisions of Cardiology and Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital.
  • Lin JL; Departments of Internal Medicine and Medical Research, MacKay Memorial Hospital, Taipei.
  • Hwang JJ; Department of Medicine, MacKay Medical College, New Taipei City.
  • Hung HF; Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan.
  • Chen WJ; Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan.
  • Hou CJ; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan.
Acta Cardiol Sin ; 39(3): 361-390, 2023 May.
Article em En | MEDLINE | ID: mdl-37229331
ABSTRACT
The prevalence of heart failure is increasing, causing a tremendous burden on health care systems around the world. Although mortality rate of heart failure has been significantly reduced by several effective agents in the past 3 decades, yet it remains high in observational studies. More recently, several new classes of drugs emerged with significant efficacy in reducing mortality and hospitalization in chronic heart failure with reduced ejection fraction (HFrEF) and preserved ejection fraction (HFpEF). To integrate these effective therapies and prioritize them in the management of Asian patients, Taiwan Society of Cardiology has recently appointed a working group to formulate a consensus of pharmacological treatment in patients with chronic heart failure. Based on most updated information, this consensus provides rationales for prioritization, rapid sequencing, and in-hospital initiation of both foundational and additional therapies for patients with chronic heart failure.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Acta Cardiol Sin Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Acta Cardiol Sin Ano de publicação: 2023 Tipo de documento: Article